SGMOQ · Sangamo Therapeutics, Inc
$0.16
+0.01 (+4.63%)
At close · Aug 28
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“There is substantial doubt about our ability to continue to operate as a going concern. We will need substantial additional funding in the very near term to execute our operating plan and to continue to operate as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$66.29M
Shares
414.29M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-05-14 | First Quarter 2026 Conference Call and Webcast | Earnings call |
| 2026-03-30 | Fourth Quarter 2025 Conference Call and Webcast | Earnings call |
| 2026-02-06 | WORLDSymposium 2026 | Event |